Comparison between SMS Pharmaceuticals IPO and Transwarranty Finance IPO.
SMS Pharmaceuticals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Transwarranty Finance IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of SMS Pharmaceuticals IPO is up to ₹98.01 Cr whereas the issue size of the Transwarranty Finance IPO is up to ₹31.20 Cr. The final issue price of SMS Pharmaceuticals IPO is ₹380.00 per share and of Transwarranty Finance IPO is ₹52.00 per share.
| SMS Pharmaceuticals IPO | Transwarranty Finance IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹360.00 per share | ₹48.00 per share |
| Issue Price (Upper) | ₹380.00 per share | ₹55.00 per share |
| Issue Price (Final) | ₹380.00 per share | ₹52.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 15 shares | 120 shares |
| Fresh Issue Size | 25,79,225 shares | 60,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹98.01 Cr | up to ₹31.20 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 25,79,225 shares | 60,00,000 shares |
| Issue Size Total (Amount) | up to ₹98.01 Cr | up to ₹31.20 Cr |
SMS Pharmaceuticals IPO opens on Feb 05, 2007, while Transwarranty Finance IPO opens on Jan 23, 2007. The closing date of SMS Pharmaceuticals IPO and Transwarranty Finance IPO is Feb 08, 2007, and Feb 02, 2007, respectively.
| SMS Pharmaceuticals IPO | Transwarranty Finance IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 05, 2007 | Jan 23, 2007 |
| Issue Close | Feb 08, 2007 | Feb 02, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Feb 28, 2007 | Feb 26, 2007 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
SMS Pharmaceuticals IPO P/E ratio is , as compared to Transwarranty Finance IPO P/E ratio of .
| SMS Pharmaceuticals IPO | Transwarranty Finance IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 72.31 | 98.16 | ||||
| Promoter Shareholding (Post-Issue) | 53.68 | 56.09 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹380.00 Cr. | ₹72.80 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 17.41 | 23.86 |
In the SMS Pharmaceuticals IPO Retail Individual Investors (RII) are offered 9,01,950 shares while in Transwarranty Finance IPO retail investors are offered 9,01,950 shares. Qualified Institutional Buyers (QIB) are offered 12,88,500 shares in SMS Pharmaceuticals IPO and 29,50,000 shares in Transwarranty Finance IPO.
| SMS Pharmaceuticals IPO | Transwarranty Finance IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 12,88,500 shares | 29,50,000 shares |
| NII | 3,86,550 shares | 8,85,000 shares |
| RII | 9,01,950 shares | 20,65,000 shares |
| Employee | 1,00,000 shares | |
| Others | ||
| Total | 25,77,000 shares | 60,00,000 shares |
SMS Pharmaceuticals IPO subscribed 2.64x in total, whereas Transwarranty Finance IPO subscribed 1.59x.
| SMS Pharmaceuticals IPO | Transwarranty Finance IPO | |
|---|---|---|
| QIB (times) | 3.47x | 1.03x |
| NII (times) | 0.28x | 1.87x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.47x | 2.34x |
| Employee (times) | 0.24x | |
| Other (times) | ||
| Total (times) | 2.64x | 1.59x |
